| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/07/2011 | CN101703555B Health care medicinal liquor for tonifying kidney |
| 09/07/2011 | CN101664404B Fragrant solomonseal rhizome isoflavanone extract as well as preparation method and application thereof |
| 09/07/2011 | CN101628101B Medicine combination and application thereof in preparing preparations for treating premature ovarian failure |
| 09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
| 09/07/2011 | CN101194993B Umbilicus applying medicament for treating children's nocturia |
| 09/07/2011 | CN101035433B Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| 09/06/2011 | US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2011 | WO2011105099A1 Compound containing a novel 4-alkoxypyridine formation and medicine containing same |
| 09/01/2011 | WO2011104338A1 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | WO2011104337A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | WO2011104334A1 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | WO2011084548A8 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110213004 Method of using combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor |
| 09/01/2011 | US20110212989 Therapeutic methods and compositions involving isoflavones |
| 09/01/2011 | US20110212984 Use of (3r)-4--3-(4-chlorophenyl) butanoic acid for treating urinary incontinence |
| 09/01/2011 | US20110212973 Carbamate compound or salt thereof |
| 09/01/2011 | US20110212959 Cyanoisoquinoline Compounds and Methods of Use Thereof |
| 09/01/2011 | US20110212952 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (vri) activity |
| 09/01/2011 | US20110212944 2-oxo-1-pyrrolidine derivatives |
| 09/01/2011 | US20110212940 S1P Receptor Modulating Compounds and Use Thereof |
| 09/01/2011 | US20110212923 Phosphate Derivatives of Substituted Benzoxazoles |
| 09/01/2011 | US20110212884 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212188 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 09/01/2011 | US20110212175 Combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor |
| 09/01/2011 | US20110212103 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 09/01/2011 | US20110212102 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212083 Role of soluble upar in the pathogenesis of proteinuric kidney disease |
| 09/01/2011 | US20110212079 Adaptive biochemical signatures |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | CA2791105A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | CA2791103A1 4 - [cycloalkyloxy (hetero) arylamino] thieno [2,3-d] pyrimidines having mnk1/ mnk2 inhibiting activity for pharmaceutical compositions |
| 08/31/2011 | EP2361910A1 Compound having tafia inhibitory activity |
| 08/31/2011 | EP2361907A1 The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof |
| 08/31/2011 | EP2361635A2 Anti IgE vaccines |
| 08/31/2011 | EP2361631A1 Treatment of alpha-galactosidase a deficiency |
| 08/31/2011 | EP2361303A1 An isolated multipotent mesenchymal stem cell from human adult glomeruli (hgl-msc), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney |
| 08/31/2011 | EP1467712B2 Method of producing a bilayer pharmaceutical tablet comprising telmisartan and hydrochlorothiazide |
| 08/31/2011 | CN1989972B Finasteroid oral preparation and method for preparing same |
| 08/31/2011 | CN1659162B Tricyclic thrombin receptor antagonists |
| 08/31/2011 | CN102171329A Lactic acid bacterium having high oxalic acid decomposition ability |
| 08/31/2011 | CN102171192A Indazole compound |
| 08/31/2011 | CN102171191A Indazole derivative |
| 08/31/2011 | CN102170878A Controlled release pharmaceutical composition |
| 08/31/2011 | CN102170872A Method of modulating membrane potential of a cell |
| 08/31/2011 | CN102166357A Medicinal composition containing bicyclic aza-alkane derivative |
| 08/31/2011 | CN102166345A Medicinal composition containing small amount of desmopressin |
| 08/31/2011 | CN102166294A Common anemarrhena polysaccharide extractive and preparation method and medicinal purposes thereof |
| 08/31/2011 | CN102166264A Shenshitong quality control method |
| 08/31/2011 | CN102166248A Rape pollen extract and preparation method and application thereof |
| 08/31/2011 | CN102166215A Pharmaceutical composition containing piperazine derivatives |
| 08/31/2011 | CN101912365B Sulbenicillin sodium powder injection and preparation process thereof |
| 08/31/2011 | CN101884722B Medicament for treating chyluria and preparation method thereof |
| 08/31/2011 | CN101850020B Chinese medicament for treating chronic kidney failure |
| 08/31/2011 | CN101700387B Compound snow ginseng capsule |
| 08/31/2011 | CN101395134B 17 beta hsd type 5 inhibitor |
| 08/31/2011 | CN101293054B Chinese Medicinal composition for treating kidney Qi deficiency |
| 08/31/2011 | CN101011480B Method for overall monitoring for kidney-tonifying body-strengthening tablet quality |
| 08/30/2011 | US8008483 sEH inhibitors and their use |
| 08/30/2011 | US8008437 Prostatic/ovarian tumor antigen for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 08/30/2011 | US8008300 Therapeutic agents useful for treating pain |
| 08/30/2011 | US8008256 Disintegrin and microtubule stabilizing agent (small molecule cell division inhibitor); preventing metastasis |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | CA2440473C Metalloproteinase inhibitors |
| 08/30/2011 | CA2436407C Polymer conjugates of neublastin and methods of using same |
| 08/30/2011 | CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 08/30/2011 | CA2393352C Adamantane derivatives |
| 08/25/2011 | WO2011102657A2 Composition for percutaneous administration of tolterodine with improved skin permeation |
| 08/25/2011 | WO2011102655A2 Composition for percutaneous administration of tolterodine with reduced skin irritation |
| 08/25/2011 | WO2011102483A1 HUMAN LAP TGF-β BINDING ANTIBODY |
| 08/25/2011 | WO2011102436A1 Tgf-β signal transduction inhibitor |
| 08/25/2011 | US20110207783 Renin inhibitors |
| 08/25/2011 | US20110207769 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester |
| 08/25/2011 | US20110207763 8-carboxamido-2,6-methano-3-benzazocines |
| 08/25/2011 | US20110207741 Activation of the Renin-Angiotensin System (RAS) and Sudden Cardiac Death |
| 08/25/2011 | US20110207670 Compositions and methods of use for soluble thrombomodulin variants |
| 08/25/2011 | US20110206668 Methods and compositions for modulating immunity |
| 08/25/2011 | US20110206653 Tetrazole compounds for reducing uric acid |
| 08/25/2011 | DE102010008981A1 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie A silicon-containing biologically degradable material for pro-angiogenic therapy |
| 08/24/2011 | EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/24/2011 | EP2359855A2 Methods of administering anti-TNFalpha antibodies |
| 08/24/2011 | EP2358688A2 Antagonists of lysophosphatidic acid receptors |
| 08/24/2011 | EP2358382A2 NOVEL USES OF VEGFxxxB |
| 08/24/2011 | EP1901775B1 Kinin antagonists for treating bladder dysfunction |
| 08/24/2011 | EP1571155B1 Peptides and medicinal compositions containing the same |
| 08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
| 08/24/2011 | EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases |
| 08/24/2011 | CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides |
| 08/24/2011 | CN102164940A TGR5 modulators and methods of use thereof |
| 08/24/2011 | CN102164596A Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient |
| 08/24/2011 | CN102161984A Method for isolating tetramer uric acid oxydiazing enzyme |
| 08/24/2011 | CN102161963A Grass root wine and preparation method thereof |
| 08/24/2011 | CN102161653A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 08/24/2011 | CN102161643A Heterocyclic carboxylic acid derivative and application as endothelin receptor antagonist thereof |
| 08/24/2011 | CN102161627A Omega-(N-substituted-aminoalkyl)octanamide |
| 08/24/2011 | CN102161619A Ferulic acid Jiangtang compound salt as well as preparation method and application thereof |
| 08/24/2011 | CN101884747B Traditional Chinese medicine for treating chronic nephritis |